ArticleScientific reports2019
Prevalence, awareness, treatment, and control of hypertension in southwestern China.
Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Systematic literature review and meta-analysis of cardiovascular risk factor management in selected Asian countries.Journal of comparative effectiveness research · 2023Pooled it
- Prevalence of Diabetes and Hypertension among Hajj Pilgrims: A Systematic Review.International journal of environmental research and public health · 2021Pooled it
- Explainable machine learning for hypertension prevalence classification: a cross-sectional study in Hainan Province, China.Frontiers in cardiovascular medicine · 2026Article
- Epidemiological features of hypertension in a high-altitude population in Tibet, China: a cross-sectional study.BMC public health · 2025Article
- Practice and Effect Evaluation of Hypertension Homogenization Management Model Under the "Walking Hospital" Mode in Primary Medical Institutions.International journal of general medicine · 2025Article
- Awareness of hypertension-related complications and its determinants among adult hypertensive patients in Ethiopia.Frontiers in cardiovascular medicine · 2025Article
- Association and interaction analysis of NLRP3 gene polymorphisms with hypertension risk: a case-control study in China.BMC cardiovascular disorders · 2024Article
- Investigation of vascular risk factor control and secondary prevention medication compliance in acute ischemic stroke.Frontiers in neurology · 2024Article
- Analysis of prescription status of antihypertensive drugs in Chinese patients with hypertension based on real-world study.Annals of medicine · 2023Article
- Factors Influencing the Control of Hypertension According to the Gender of Older Adults.Healthcare (Basel, Switzerland) · 2023Article
- Socioeconomic inequalities in prevalence, awareness, treatment and control of hypertension: evidence from the PERSIAN cohort study.BMC public health · 2022Article
- Association of obesity anthropometric indices with hypertension, diabetes mellitus and hypertriglyceridemia in apparently healthy adult Nigerian population.World journal of cardiology · 2022Article
- Prevalence of hypertension in Shenzhen, China: a population-based, cross-sectional study.BMJ open · 2022Article
- Epidemiological status quo of hypertension in elderly population in Changchun, China: a cross-sectional study.BMJ open · 2022Article
- High prevalence and low awareness of hyperuricemia in hypertensive patients among adults aged 50-79 years in Southwest China.BMC cardiovascular disorders · 2022Article
- The prevalence of obesity-related hypertension among middle-aged and older adults in China.Frontiers in public health · 2022Article
- Prevalence and related factors of dyslipidemia among urban adults aged 35 to 79 years in Southwestern China.Scientific reports · 2021Article
- Spatiotemporal Analysis of the Prevalence and Pattern of Multimorbidity in Older Chinese Adults.Frontiers in medicine · 2021Article
- Article
- Prevalence and associated factors of hyperuricemia among urban adults aged 35-79 years in southwestern China: a community-based cross-sectional study.Scientific reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated the prevalence, awareness, treatment, and control of hypertension and associated factors among urban adults in southwestern China. The study was conducted from 2013-2014 and used a multistage cluster sampling method to select a representative sample of 11,517 people in southwestern China, aged 35-79 years. Hypertension was defined as either systolic blood pressure of 140 mmHg or greater, diastolic blood pressure of 90 mm Hg or greater, or self-reported current treatment for hypertension with antihypertensive medications. In the study population, hypertension prevalence was found to be 38.4%, with rates of 40.0% and 37.5% for men and women, respectively (p = 0.03). Hypertension prevalence increased with age in both men and women (trend p both <0.01). Among hypertensive patients, 47.9% were aware of their hypertension, 40.1% were undergoing antihypertensive treatment, and 10.3% achieved BP control. A multiple-factor analysis revealed that age, male gender, low educational achievement, family history of hypertension, overweight or obesity, abdominal obesity, and hypertriglyceridemia were positively related to hypertension, while physical exercise was negatively related to hypertension. The prevalence of hypertension among urban adults aged 35 to 79 years in southwestern China was high, while levels of awareness, treatment, and control of hypertension were low. Multifaceted interventional measures are needed to solve the unmet needs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.